Malaria vaccine development: An endemic country perspective

Human Vaccines

Volumn 6, Issue 1, 2010, Pages

  Koram, Kwadwo A ^a   Gyan, Ben A ^a  

^a University of Ghana   (Ghana)

Author keywords

Malaria; Malaria endemic countries; Vaccines

Indexed keywords

MALARIA VACCINE;

CLINICAL TRIAL; DRUG MANUFACTURE; DRUG RESEARCH; DRUG UTILIZATION; ENDEMIC DISEASE; HIGH RISK POPULATION; HUMAN; IMMUNE RESPONSE; INFECTION RISK; MALARIA; MALARIA CONTROL; NONHUMAN; PARASITE TRANSMISSION; PREGNANT WOMAN; REVIEW; VACCINATION; CHILD; DRUG APPROVAL; FEMALE; IMMUNOLOGY; INFANT; NEWBORN; ORGANIZATION AND MANAGEMENT; PREGNANCY; PRESCHOOL CHILD; TRANSLATIONAL RESEARCH;

CHILD; CHILD, PRESCHOOL; CLINICAL TRIALS AS TOPIC; DRUG APPROVAL; ENDEMIC DISEASES; FEMALE; HUMANS; INFANT; INFANT, NEWBORN; MALARIA; MALARIA VACCINES; PREGNANCY; TRANSLATIONAL RESEARCH;

EID: 74949116408     PISSN: 15548600     EISSN: 15548619     Source Type: Journal    
DOI: 10.4161/hv.6.1.9605     Document Type: Review

References (36)

1. Russell PF. Man's mastery of malaria. Oxford: Oxford University Press 1955.
2. Cleaver H. Malaria and the Political Economy of Public Health. Intl Journal of Health Services 1977; 7:557-9.
3. Trape JF. The public health impact of chloroquine resistance in Africa. Am J Trop Med Hyg 2001; 64:12-7.
4. Snow RW, Korenromp EL, Gouws E. Pediatric Mortality in Africa: Plasmodium falciparum as a Cause or Risk? Am J Trop Med Hyg 2004; 71:16-24.
5. Breman JG. The ears of the hippopotamus: manifestations, determinants and estimates of malaria burden. Am J Trop Med Hyg 2001; 64:1-11.
6. WHO factsheet. http://www.who.int1/mediacentre/ factsheets/fs094/en/.
7. Murphy SC, Breman JG. Gaps in the childhood malaria burden in Africa: Cerebral malaria, neurological sequelae, anaemia, respiratory distress, hypoglycaemia and complications pregnancy. Am J Trop Med Hyg 2001; 64:57-67.
8. Sachs J, Malaney P. The economic and social burden of malaria. Nature 2002; 415:680-5.
9. Gallup JL, Sachs JD. The economic burden of malaria. Am J Trop Med Hyg 2001; 64:85-96.
10. Chima RI, Goodman CA, Mills A. The economic impact of malaria in Africa: a critical review of the evidence. Health Policy 2000; 63:17-36.
11. Talisuna AO, Bloland P, D'Alanssandro U. History, Dynamics and Public Health Importance of Malaria Parasite Resistance. Clin Microbiol Rev 2004; 235-54.
12. Koram KA, Abuaku B, Duah, Quashie N. Comparative Efficacy of Antimalarial Drugs Including ACTs in the Treatment of Uncomplicated Malaria Among Children Under 5 Years in Ghana. Acta Tropica 2005; 95:194-203.
13. Duffy P, Mutabingwa TK. Artemisinin Combination Therapies. The Lancet 2006; 367:2037-9.
14. Rogers WO, Sem R, Tero T, Chim P, Lim P, Muth S, et al. Failure of artesunate-mefloquine combination therapy for uncomplicated Plasmodium falciparum malaria in Southern Cambodia. Malaria Journal. Malaria Journal 2009; 8:10; doi:10.1186/1475-2875-8-10.
15. Gomez PL, Robinson JM, Rogalewicz J. Vaccine Manufacturing. In: Plotkin S, Orenstein W, Offit P, eds. Vaccines 5th Edition Saunders Elsevier 2008; 45-58.
16. Pierce SK, Miller LH. World Malaria Day 2009: What malaria mnows about the immune system that immunologists still do not. J Immunol 2009; 182:5171-7.
17. Rogers WO, Atuguba F, Oduro AR, Hodgson AVO, Koram KA. Malaria case definitions and malaria vaccine efficacy. J Infect Dis 2006; 193:467-73.
18. Koram KA, Molyneux ME. When Is "Malaria" malaria? The different burdens of malaria infection, malaria disease and malaria-like illnesses. Am J Trop Med Hyg 2007; 77:1-5.
19. McGuinness D, Koram KA, Bennett S, Wagner G, Nkrumah F, Riley E. Clinical case definitions for malaria: clinical malaria associated with very low parasite densities in African infants. Trans Roy Soc Trop Med Hyg 1998; 92:527-31.
20. Rogers WO, Hoffman SL. Malaria vaccines. In: Walgren M, Perlmann P, eds. Malaria: Molecular and Clinical Aspects. Harwood Academic Publishers CRC 1999; 439-93.
21. Matuschewski K, Mueller A-K. Vaccines against malaria -an update. FEBS Journal 2007; 274:4680-7.
22. Sharma S, Pathak S. Malaria vaccine: a current perspective. J Vector Borne Dis 2008; 1-20.
23. Druilhe P, Barnwell JW. Pre-erythrocytic stage malaria vaccines: time for a change in path. Current Opinion in Microbiology 2007; 10:371-8.
24. Michael F. Ofori, Daniel Dodoo, Trine Staalsoe, Jørgen A.L. Kurtzhals, Kwadwo A. Koram, Thor G. Theander, et al. Malaria-induced acquisition of antibodies to Plasmodium falciparum variant surface antigens. Infection and Immunity 2002; 70:2982-8.
25. Moorthy VS, Good MF, Hill AVS. Malaria vaccine developments. The Lancet 2004; 363:150-6.
26. Greenwood BM, Alonso P. Malaria vaccine trials. In: Perlmann P, Troye-Blomberg M, eds. Malaria Immunology. Chemical Immunology 2002; 80:366-95.
27. Targett GA, Greenwood BM. Malaria vaccines and their potential role in the elimination of malaria. Malaria Journal 2008; 7:10; doi:10.1186/1475-2875-7- S1-S10.
28. Hoffman SL, Goh LM, Luke TC, Schneider I, Le TP, Doolan DL, et al. Protection of humans against malaria by immunization with radiation-attenuated Plasmodium falciparum sporozoites. J Infect Dis 2002; 185:1155-64.
29. www.sanaria.com.
30. Alonso PL, Sacarlal J, Aponte JJ, Leach A, Macete E, Milman J, et al. Efficacy of the RTS,S/ASO2A vaccine against Plasmodium falciparum infection and disease in young African children: randomized controlled trial. The Lancet 2004; 364:1411-20.
31. Alonso PL, Sacarlal J, Aponte JJ, Leach A, Macete E, Aide P, et al. Duration of protection with RTS,S/ AS02A malaria vaccine in prevention of Plasmodium falciparum disease in Mozambican children: singleblind extended follow-up of a randomised controlled trial. The Lancet 2005; 366:2012-8.
32. Carter R, Mendis KN, Miller LH, Molineaux L, Saul A. Malaria transmission-blocking vaccines-how can their development be supported? Nature Medicine 2000; 6:241-4.
33. Kilama WL. Ethical perspectives on malaria research for Africa. Acta Tropica 2005; 95:276-84.
34. Kilama WL. Malaria vaccines in Africa. Acta Tropica 2003; 88:153-9.
35. Plebanski M, Lopez E, Proudfoot O, Cooke BM, von Itzstein M, Coppell RL. Economic and practical challenges to the formulation of vaccines against endemic infectious diseases such as malaria. Methods 2006; 40:77-85.
36. Moree M, Ewart S. Policy challenges in malaria vaccine introduction. Am J Trop Med Hyg 2004; 71:248-52.